Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine’s efficacy in treating asthma patients and is not currently approved for this indication.

11 Sep 2013

Phobias, anxiety are typical reasons why many decline to donate blood

As few as 3 percent of Americans eligible to donate blood do, and fear and anxiety are common reasons why many decline to give. U.S. hospitals are always in need of new donors; at Mayo Clinic, that need is heightened by concern about iron deficiency in frequent givers.

11 Sep 2013

State highlights: Texas Gov. Perry touts tort reform; Calif. lawmakers want to pass 100 bills per day

A measles outbreak in a vaccination-wary North Texas megachurch and soaring rates of whooping cough across the state are drawing renewed calls for immunization legislation, which some lawmakers and medical professionals argue would help the state prevent public health crises (Aaronson, 9/10).

11 Sep 2013

Personalized treatment may be effective in wild type cancers

As a woman in her mid-forties who didn't smoke, Elizabeth Lacasia never expected to be diagnosed with lung cancer. But in 2006, after she developed a persistent and serious cough, a chest X-ray and CT scan revealed several tumors in her lower left lung.

11 Sep 2013

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more than 100 people, primarily in the Middle East.

10 Sep 2013

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Boehringer Ingelheim today announced the completion of patient enrolment for a Phase IIa clinical trial investigating a new interferon-free, all-oral, direct-acting antiviral combination treatment for patients with genotype-1a chronic hepatitis C virus infection.

10 Sep 2013

First Edition: September 10, 2013

Today's headlines include reports from Capitol Hill about the GOP strategy to link debate of a stopgap spending bill to keep the government operating to efforts to defund the health law.

10 Sep 2013

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.

10 Sep 2013

Patients with COPD show improvements in lung function with olodaterol

Data from the olodaterol Phase 3 clinical program, presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, showed the addition of olodaterol 5 and 10 µg delivered once daily via the Respimat® inhaler provided improvements in lung function in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

10 Sep 2013

New prescribing protocol could reduce potential misuse of antibiotics

Researchers have developed a new strategy for prescribing antibiotics that could reduce patient harm and help combat the rise in antibiotic resistance.

10 Sep 2013

Findings could lead to improvements in pneumonia care, outcomes for patients

An electronic decision support tool helped to reduce deaths from pneumonia in four hospital emergency departments in a new study.

10 Sep 2013

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche and Inovio Pharmaceuticals, Inc. announced today that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B.

10 Sep 2013

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

National Institutes of Health (NIH) scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

10 Sep 2013

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

A research team at Cold Spring Harbor Laboratory has used a recently developed technology they call TSUNAMI to create the first animal model of the adult-onset version of spinal muscular atrophy, a devastating motor-neuron illness.

10 Sep 2013

Emerging H7N9 virus has potential to cause a pandemic

A new study has found that a novel avian-origin H7N9 influenza A virus, which has recently emerged in humans, attaches moderately or abundantly to the epithelium of both the upper and lower respiratory tracts.

10 Sep 2013

Scientists identify RNA regulator that plays critical role in proper functioning of hESCs

Scientists at A*STAR's Genome Institute of Singapore, in collaboration with their counterparts from Canada, Hong Kong and US, have discovered a protein mediator SON plays a critical role in the health and proper functioning of human embryonic stem cells. This finding was reported on 8th September 2013 in the advanced online issue of the prestigious science journal Nature Cell Biology.

10 Sep 2013

New technology to diagnose influenza quickly

A new technology is showing promise as the basis for a much-needed home test to diagnose influenza quickly, before the window for taking antiviral drugs slams shut and sick people spread the virus to others, scientists reported here today. In a presentation at the 246th National Meeting & Exposition of the American Chemical Society (ACS), they described how it also could determine the specific strain of flu virus and help select the most effective drug for treatment.

10 Sep 2013

Undervaccination with diptheria increases risk of whooping cough

Undervaccination with the diptheria, tetanus toxoids and acelluar pertussis (DTaP) vaccine appears to be associated with an increased risk of pertussis (whooping cough) in children 3 to 36 months of age, according to a study by Jason M. Glanz, Ph.D., of the Institute for Health Research at Kaiser Permanente Colorado, Denver.

10 Sep 2013

Sam's Club Pharmacy to host free health screenings for diabetes

To promote early detection and an overall healthy lifestyle that can help prevent the onset of diabetes, Sam's Club Pharmacy will host free health screenings Saturday, Sept. 14, from 11 a.m. to 3 p.m.

7 Sep 2013

Simple changes in family's lifestyle helps 12-year-old to fight diabetes

Simple changes in a family's lifestyle can stop chronic illnesses in children before they start. For 12-year-old Austin Stanfill, a makeover of his family's diet allowed him to prevent a type-2 diabetes diagnosis.

7 Sep 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Phobias, anxiety are typical reasons why many decline to donate blood

State highlights: Texas Gov. Perry touts tort reform; Calif. lawmakers want to pass 100 bills per day

Personalized treatment may be effective in wild type cancers

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

First Edition: September 10, 2013

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Patients with COPD show improvements in lung function with olodaterol

New prescribing protocol could reduce potential misuse of antibiotics

Findings could lead to improvements in pneumonia care, outcomes for patients

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

Emerging H7N9 virus has potential to cause a pandemic

Scientists identify RNA regulator that plays critical role in proper functioning of hESCs

New technology to diagnose influenza quickly

Undervaccination with diptheria increases risk of whooping cough

Sam's Club Pharmacy to host free health screenings for diabetes

Simple changes in family's lifestyle helps 12-year-old to fight diabetes

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in